Simon James Yvon Saxby
Algemeen Directeur bij Cobra Biologics Holdings Ltd.
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Peter Coleman | M | 57 |
Cobra Biologics Holdings Ltd.
 Cobra Biologics Holdings Ltd. BiotechnologyHealth Technology Cobra Biomanufacturing Plc manufactures biological products for clinical studies and clients in the pharmaceutical and biotech industries. It designs and manufactures novel proteins, viruses and additional cell products. It provides DNA-based technologies, services and products. Its services include: DNA, virus and protein manufacturing, cell banking, process development, analytical services and quality assurance and regulatory support. It uses mammalian and microbial host cells for numerous therapeutic protein developments. It also provides a range of DNA maintenance technology, such as its ORT, ORT-VAC and RiboCLEAR programs. The company is headquartered in Newcastle, the United Kingdom. | 22 jaar |
| William John Edward Burt | M | 56 |
Leaf Systems International Ltd.
 Leaf Systems International Ltd. Pharmaceuticals: OtherHealth Technology Leaf Systems International Ltd. is a contract research and British product development company that specializes in cutting-edge plant-based expression and production of proteins. The company is based in Norwich, UK. The company has a strong focus on research and development, utilizing their versatile technology and knowledge of plant biotechnology. The CEO of the company is Simon James Yvon Saxby. | - |
| Sheena Pumford | M | - |
Cobra Biologics Holdings Ltd.
Cobra Biologics Holdings Ltd. BiotechnologyHealth Technology Cobra Biomanufacturing Plc manufactures biological products for clinical studies and clients in the pharmaceutical and biotech industries. It designs and manufactures novel proteins, viruses and additional cell products. It provides DNA-based technologies, services and products. Its services include: DNA, virus and protein manufacturing, cell banking, process development, analytical services and quality assurance and regulatory support. It uses mammalian and microbial host cells for numerous therapeutic protein developments. It also provides a range of DNA maintenance technology, such as its ORT, ORT-VAC and RiboCLEAR programs. The company is headquartered in Newcastle, the United Kingdom. | 27 jaar |
| David John Simpson | M | - |
Leaf Systems International Ltd.
Leaf Systems International Ltd. Pharmaceuticals: OtherHealth Technology Leaf Systems International Ltd. is a contract research and British product development company that specializes in cutting-edge plant-based expression and production of proteins. The company is based in Norwich, UK. The company has a strong focus on research and development, utilizing their versatile technology and knowledge of plant biotechnology. The CEO of the company is Simon James Yvon Saxby. | - |
| Georgina Anne Pope | M | 49 |
Leaf Systems International Ltd.
Leaf Systems International Ltd. Pharmaceuticals: OtherHealth Technology Leaf Systems International Ltd. is a contract research and British product development company that specializes in cutting-edge plant-based expression and production of proteins. The company is based in Norwich, UK. The company has a strong focus on research and development, utilizing their versatile technology and knowledge of plant biotechnology. The CEO of the company is Simon James Yvon Saxby. | - |
| Colin Malcolm Miles | M | - |
Leaf Systems International Ltd.
Leaf Systems International Ltd. Pharmaceuticals: OtherHealth Technology Leaf Systems International Ltd. is a contract research and British product development company that specializes in cutting-edge plant-based expression and production of proteins. The company is based in Norwich, UK. The company has a strong focus on research and development, utilizing their versatile technology and knowledge of plant biotechnology. The CEO of the company is Simon James Yvon Saxby. | - |
| Simon Eric Aspland | M | - |
Leaf Systems International Ltd.
Leaf Systems International Ltd. Pharmaceuticals: OtherHealth Technology Leaf Systems International Ltd. is a contract research and British product development company that specializes in cutting-edge plant-based expression and production of proteins. The company is based in Norwich, UK. The company has a strong focus on research and development, utilizing their versatile technology and knowledge of plant biotechnology. The CEO of the company is Simon James Yvon Saxby. | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| David A. Thatcher | M | - |
Cobra Biologics Holdings Ltd.
Cobra Biologics Holdings Ltd. BiotechnologyHealth Technology Cobra Biomanufacturing Plc manufactures biological products for clinical studies and clients in the pharmaceutical and biotech industries. It designs and manufactures novel proteins, viruses and additional cell products. It provides DNA-based technologies, services and products. Its services include: DNA, virus and protein manufacturing, cell banking, process development, analytical services and quality assurance and regulatory support. It uses mammalian and microbial host cells for numerous therapeutic protein developments. It also provides a range of DNA maintenance technology, such as its ORT, ORT-VAC and RiboCLEAR programs. The company is headquartered in Newcastle, the United Kingdom. | - |
| David Aufrere Oxlade | M | 74 |
Cobra Biologics Holdings Ltd.
Cobra Biologics Holdings Ltd. BiotechnologyHealth Technology Cobra Biomanufacturing Plc manufactures biological products for clinical studies and clients in the pharmaceutical and biotech industries. It designs and manufactures novel proteins, viruses and additional cell products. It provides DNA-based technologies, services and products. Its services include: DNA, virus and protein manufacturing, cell banking, process development, analytical services and quality assurance and regulatory support. It uses mammalian and microbial host cells for numerous therapeutic protein developments. It also provides a range of DNA maintenance technology, such as its ORT, ORT-VAC and RiboCLEAR programs. The company is headquartered in Newcastle, the United Kingdom. | 4 jaar |
| Michael Gatenby | M | 79 |
Cobra Biologics Holdings Ltd.
Cobra Biologics Holdings Ltd. BiotechnologyHealth Technology Cobra Biomanufacturing Plc manufactures biological products for clinical studies and clients in the pharmaceutical and biotech industries. It designs and manufactures novel proteins, viruses and additional cell products. It provides DNA-based technologies, services and products. Its services include: DNA, virus and protein manufacturing, cell banking, process development, analytical services and quality assurance and regulatory support. It uses mammalian and microbial host cells for numerous therapeutic protein developments. It also provides a range of DNA maintenance technology, such as its ORT, ORT-VAC and RiboCLEAR programs. The company is headquartered in Newcastle, the United Kingdom. | - |
| Danny R. Chapchal | M | - |
Cobra Biologics Holdings Ltd.
Cobra Biologics Holdings Ltd. BiotechnologyHealth Technology Cobra Biomanufacturing Plc manufactures biological products for clinical studies and clients in the pharmaceutical and biotech industries. It designs and manufactures novel proteins, viruses and additional cell products. It provides DNA-based technologies, services and products. Its services include: DNA, virus and protein manufacturing, cell banking, process development, analytical services and quality assurance and regulatory support. It uses mammalian and microbial host cells for numerous therapeutic protein developments. It also provides a range of DNA maintenance technology, such as its ORT, ORT-VAC and RiboCLEAR programs. The company is headquartered in Newcastle, the United Kingdom. | - |
| Nigel Slater | M | 70 |
Cobra Biologics Holdings Ltd.
Cobra Biologics Holdings Ltd. BiotechnologyHealth Technology Cobra Biomanufacturing Plc manufactures biological products for clinical studies and clients in the pharmaceutical and biotech industries. It designs and manufactures novel proteins, viruses and additional cell products. It provides DNA-based technologies, services and products. Its services include: DNA, virus and protein manufacturing, cell banking, process development, analytical services and quality assurance and regulatory support. It uses mammalian and microbial host cells for numerous therapeutic protein developments. It also provides a range of DNA maintenance technology, such as its ORT, ORT-VAC and RiboCLEAR programs. The company is headquartered in Newcastle, the United Kingdom. | - |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigd Koninkrijk | 12 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Simon James Yvon Saxby
- Persoonlijk netwerk
